Massachusetts Financial Services CO Novo Nordisk A S Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

A detailed history of Massachusetts Financial Services CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Massachusetts Financial Services CO holds 79,660 shares of NVO stock, worth $6.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,660
Previous 77,494 2.8%
Holding current value
$6.96 Million
Previous $11.1 Million 14.25%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$119.07 - $145.42 $257,905 - $314,979
2,166 Added 2.8%
79,660 $9.49 Million
Q2 2024

Aug 09, 2024
BUY
$122.71 - $146.91 $228,240 - $273,252
1,860 Added 2.46%
77,494 $11.1 Million
Q1 2024

May 14, 2024
BUY
$102.11 - $135.92 $283,355 - $377,177
2,775 Added 3.81%
75,634 $9.71 Million
Q4 2023

Feb 08, 2024
SELL
$87.78 - $105.45 $70.3 Million - $84.4 Million
-800,735 Reduced 91.66%
72,859 $7.54 Million
Q3 2023

Nov 08, 2023
BUY
$90.94 - $199.54 $7.01 Million - $15.4 Million
77,061 Added 9.67%
873,594 $79.4 Million
Q2 2023

Aug 09, 2023
BUY
$155.98 - $172.65 $118 Million - $131 Million
756,836 Added 1906.53%
796,533 $129 Million
Q1 2023

May 10, 2023
BUY
$132.34 - $159.14 $234,374 - $281,836
1,771 Added 4.67%
39,697 $6.32 Million
Q4 2022

Feb 13, 2023
SELL
$102.55 - $135.33 $799,172 - $1.05 Million
-7,793 Reduced 17.05%
37,926 $5.13 Million
Q3 2022

Nov 09, 2022
SELL
$95.28 - $116.93 $248,299 - $304,719
-2,606 Reduced 5.39%
45,719 $4.56 Million
Q2 2022

Aug 09, 2022
SELL
$103.24 - $121.81 $617,684 - $728,789
-5,983 Reduced 11.02%
48,325 $5.39 Million
Q1 2022

May 11, 2022
BUY
$93.1 - $112.54 $319,426 - $386,124
3,431 Added 6.74%
54,308 $6.03 Million
Q4 2021

Feb 10, 2022
SELL
$95.88 - $117.08 $2.18 Million - $2.66 Million
-22,743 Reduced 30.89%
50,877 $5.7 Million
Q3 2021

Nov 10, 2021
SELL
$84.42 - $106.62 $3.58 Million - $4.52 Million
-42,420 Reduced 36.56%
73,620 $7.07 Million
Q2 2021

Aug 13, 2021
BUY
$67.66 - $84.76 $466,921 - $584,928
6,901 Added 6.32%
116,040 $9.72 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $902,828 - $1.02 Million
13,463 Added 14.07%
109,139 $7.36 Million
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $212,881 - $245,901
3,332 Added 3.61%
95,676 $6.68 Million
Q3 2020

Nov 12, 2020
BUY
$63.69 - $70.22 $203,489 - $224,352
3,195 Added 3.58%
92,344 $6.41 Million
Q2 2020

Aug 11, 2020
SELL
$58.54 - $67.94 $979,725 - $1.14 Million
-16,736 Reduced 15.81%
89,149 $5.84 Million
Q1 2020

May 14, 2020
BUY
$49.46 - $64.78 $332,222 - $435,127
6,717 Added 6.77%
105,885 $6.37 Million
Q4 2019

Feb 13, 2020
BUY
$49.86 - $58.26 $71,598 - $83,661
1,436 Added 1.47%
99,168 $5.74 Million
Q3 2019

Nov 05, 2019
SELL
$47.54 - $53.43 $175,898 - $197,691
-3,700 Reduced 3.65%
97,732 $5.05 Million
Q2 2019

Aug 14, 2019
BUY
$46.79 - $52.47 $68,547 - $76,868
1,465 Added 1.47%
101,432 $5.18 Million
Q1 2019

May 13, 2019
BUY
$46.36 - $52.63 $547,789 - $621,876
11,816 Added 13.4%
99,967 $5.23 Million
Q4 2018

Feb 08, 2019
SELL
$41.54 - $47.25 $111,950 - $127,338
-2,695 Reduced 2.97%
88,151 $4.06 Million
Q3 2018

Oct 25, 2018
SELL
$46.76 - $51.24 $47,741 - $52,316
-1,021 Reduced 1.11%
90,846 $4.28 Million
Q2 2018

Jul 30, 2018
BUY
$44.29 - $50.42 $38,355 - $43,663
866 Added 0.95%
91,867 $4.24 Million
Q1 2018

May 04, 2018
BUY
$48.49 - $58.14 $1.03 Million - $1.23 Million
21,231 Added 30.43%
91,001 $4.48 Million
Q4 2017

Feb 14, 2018
BUY
$47.53 - $53.73 $149,481 - $168,980
3,145 Added 4.72%
69,770 $3.75 Million
Q3 2017

Nov 14, 2017
BUY
$41.15 - $49.22 $2.74 Million - $3.28 Million
66,625
66,625 $3.21 Million

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email